Endocrinology, Vol 136, 4415-4423, Copyright © 1995 by Endocrine Society

ARTICLES

Defining the major antibody epitopes on the human thyrotropin receptor in immunized mice: evidence for intramolecular epitope spreading

H Vlase, M Nakashima, PN Graves, Y Tomer, JC Morris and TF Davies
Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA.

To evaluate the B cell response to the extracellular domain of the human TSH receptor (hTSHR-ecd), we used recombinant hTSHR-ecd to immunize BALB/c mice (group A) and CBA/J mice (groups B and C). Mice from groups A and B were boosted once, and mice from group C received three antigen boosts. All individual mice developed highly specific hTSHR-ecd antibodies (hTSHR-ecd-Ab), confirmed by Western blot analyses. The B cell epitopes recognized by these murine hTSHR-ecd-Ab were mapped by enzyme-linked immunoassays using 26 synthetic overlapping peptides spanning the entire mature hTSHR-ecd [amino acids (aa) 22-415], i.e. without the signal sequence. Although all BALB/c and CBA/J mice antisera recognized peptide 1 (aa 22-41), the hyperimmunized CBA/J mice (group C) demonstrated recognition of additional peptides (numbers 21-26) clustered toward the carboxyl-terminus of the hTSHR-ecd (aa 322-415). Furthermore, group C serum blocked the binding of [125I]bTSH to native porcine TSHR, whereas sera from groups A and B were inactive. We were also able to map the B cell epitopes of antisera from rabbits immunized repeatedly with hTSHR-ecd and found the same recognition pattern of peptide 1 and additional peptides clustered near the carboxyl-terminus of the hTSHR-ecd (aa 322-341 and 367-415). These rabbit antisera also inhibited the binding of [125I]bTSH to native porcine TSHR. These data provide a comprehensive B cell epitope-mapping study of induced hTSHR-ecd-Ab and demonstrate intramolecular spreading of the epitopes recognized. Although the N-terminal region was highly antigenic, repeated immunization induced hTSHR-ecd-Ab targeted to a region critical for TSH binding.

This article has been cited by other articles:

				S. M. McLachlan, Y. Nagayama, and B. Rapoport Insight into Graves' Hyperthyroidism from Animal Models Endocr. Rev., October 1, 2005; 26(6): 800 - 832. [Abstract] [Full Text] [PDF]

				T. Ando, R. Latif, S. Daniel, K. Eguchi, and T. F. Davies Dissecting Linear and Conformational Epitopes on the Native Thyrotropin Receptor Endocrinology, November 1, 2004; 145(11): 5185 - 5193. [Abstract] [Full Text] [PDF]

				B. S. Prabhakar, R. S. Bahn, and T. J. Smith Current Perspective on the Pathogenesis of Graves' Disease and Ophthalmopathy Endocr. Rev., December 1, 2003; 24(6): 802 - 835. [Abstract] [Full Text] [PDF]

				I. Ciullo, R. Latif, P. Graves, and T. F. Davies Functional Assessment of the Thyrotropin Receptor-{beta} Subunit Endocrinology, July 1, 2003; 144(7): 3176 - 3181. [Abstract] [Full Text] [PDF]

				L. Schwarz-Lauer, P. N. Pichurin, C.-R. Chen, Y. Nagayama, C. Paras, J. C. Morris, B. Rapoport, and S. M. McLachlan The Cysteine-Rich Amino Terminus of the Thyrotropin Receptor Is the Immunodominant Linear Antibody Epitope in Mice Immunized Using Naked Deoxyribonucleic Acid or Adenovirus Vectors Endocrinology, May 1, 2003; 144(5): 1718 - 1725. [Abstract] [Full Text] [PDF]

				T. Ando, M. Imaizumi, P. Graves, P. Unger, and T. F. Davies Induction of Thyroid-Stimulating Hormone Receptor Autoimmunity in Hamsters Endocrinology, February 1, 2003; 144(2): 671 - 680. [Abstract] [Full Text] [PDF]

				C. L. Vanderlugt, K. L. Neville, K. M. Nikcevich, T. N. Eagar, J. A. Bluestone, and S. D. Miller Pathologic Role and Temporal Appearance of Newly Emerging Autoepitopes in Relapsing Experimental Autoimmune Encephalomyelitis J. Immunol., January 15, 2000; 164(2): 670 - 678. [Abstract] [Full Text] [PDF]

				P. Graves, A. Pritsker, and T. F. Davies Post-Translational Processing of the Natural Human Thyrotropin Receptor: Demonstration of More than Two Cleavage Sites J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2177 - 2181. [Abstract] [Full Text]

				M. Kita, L. Ahmad, R. C. Marians, H. Vlase, P. Unger, P. N. Graves, and T. F. Davies Regulation and Transfer of a Murine Model of Thyrotropin Receptor Antibody Mediated Graves' Disease Endocrinology, March 1, 1999; 140(3): 1392 - 1398. [Abstract] [Full Text]

				B. Rapoport, G. D. Chazenbalk, J. C. Jaume, and S. M. McLachlan The Thyrotropin (TSH)-Releasing Hormone Receptor: Interaction with TSH and Autoantibodies Endocr. Rev., December 1, 1998; 19(6): 673 - 716. [Abstract] [Full Text]

				C A von Muhlen, E K. Chan, E Angles-Cano, M J Mamula, I Garcia-De La Torre, and M J Fritzler Advances in autoantibodies in SLE Lupus, October 1, 1998; 7(8): 507 - 514. [PDF]

				S. Kikuoka, N. Shimojo, K.-I. Yamaguchi, Y. Watanabe, A. Hoshioka, A. Hirai, Y. Saito, K. Tahara, L. D. Kohn, N. Maruyama, et al. The Formation of Thyrotropin Receptor (TSHR) Antibodies in a Graves' Animal Model Requires the N-Terminal Segment of the TSHR Extracellular Domain Endocrinology, April 1, 1998; 139(4): 1891 - 1898. [Abstract] [Full Text] [PDF]

				S. Costagliola, P. Rodien, M.-C. Many, M. Ludgate, and G. Vassart Genetic Immunization Against the Human Thyrotropin Receptor Causes Thyroiditis and Allows Production of Monoclonal Antibodies Recognizing the Native Receptor J. Immunol., February 1, 1998; 160(3): 1458 - 1465. [Abstract] [Full Text] [PDF]

				V. Montani, M. Shong, S.-i. Taniguchi, K. Suzuki, C. Giuliani, G. Napolitano, J. Saito, M. Saji, B. Fiorentino, A. M. Reimold, et al. Regulation of Major Histocompatibility Class II Gene Expression in FRTL-5 Thyrocytes: Opposite Effects of Interferon and Methimazole Endocrinology, January 1, 1998; 139(1): 290 - 302. [Abstract] [Full Text] [PDF]

				A. Martin, M. Nakashima, A. Zhou, D. Aronson, A. J. Werner, and T. F. Davies Detection of Major T Cell Epitopes on Human Thyroid Stimulating Hormone Receptor by Overriding Immune Heterogeneity in Patients with Graves' Disease J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3361 - 3366. [Abstract] [Full Text] [PDF]

				W. B. Kim, H. K. Chung, H. K. Lee, L. D. Kohn, K. Tahara, and B. Y. Cho Changes in Epitopes for Thyroid-Stimulating Antibodies in Graves' Disease Sera During Treatment of Hyperthyroidism: Therapeutic Implications J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1953 - 1959. [Abstract] [Full Text] [PDF]

				S. A. Patibandla, G. S. Seetharamaiah, J. S. Dallas, N. R. Thotakura, R. L. Peake, and B. S. Prabhakar Differential Reactivities of Recombinant Glycosylated Ectodomains of Mouse and Human Thyrotropin Receptors with Patient Autoantibodies Endocrinology, April 1, 1997; 138(4): 1559 - 1566. [Abstract] [Full Text] [PDF]

				H. Vlase, N. Matsuoka, P. N. Graves, R. P. Magnusson, and T. F. Davies Folding-Dependent Binding of Thyrotropin (TSH) and TSH Receptor Autoantibodies to the Murine TSH Receptor Ectodomain Endocrinology, April 1, 1997; 138(4): 1658 - 1666. [Abstract] [Full Text] [PDF]

				J. C. Jaume, A. Kakinuma, G. D. Chazenbalk, B. Rapoport, and S. M. McLachlan Thyrotropin Receptor Autoantibodies in Serum Are Present at Much Lower Levels Than Thyroid Peroxidase Autoantibodies: Analysis by Flow Cytometry J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 500 - 507. [Abstract] [Full Text] [PDF]

				Y. Bobovnikova, P. N. Graves, H. Vlase, and T. F. Davies Characterization of Soluble, Disulfide Bond-Stabilized, Prokaryotically Expressed Human Thyrotropin Receptor Ectodomain Endocrinology, February 1, 1997; 138(2): 588 - 593. [Abstract] [Full Text] [PDF]